Home
Clinical Trials
Partnerships
Contact Us
News & Resources
Careers
About Us
Management Team
Board of Directors
Scientific and Clinical Advisory Boards
Commercial Advisory Board
Our Focus
Infectious Disease
Oncology
Our Product
Our Pipeline
Prophylactic
Therapeutic
Clinical Trials
Publications
Early/Expanded Access Policy
Our Science
Investors
Press Releases
Events and Presentations
Company Information
Stock Information
SEC Filings
Corporate Governance
About Us
Management Team
Board of Directors
Scientific and Clinical Advisory Boards
Commercial Advisory Board
Our Focus
Infectious Diseases
Oncology
Our Pipeline
Prophylactic
Therapeutic
Clinical Trials
Publications
Early/Expanded Access Policy
Our Product
Our Science and Technology
News and Resources
News
Posters
Publications
Videos
Investors
Press Releases
Company Information
Corporate Governance
Events and Presentations
SEC Filings
Stock Information
Careers
Partnerships
Contact Us
Search our website
Cytomegalovirus (“CMV”)
VBI Vaccines Announces Poster Presentation at the 7th International Congenital CMV Conference & 17th International CMV Workshop
April 3rd, 2019
VBI Vaccines Provides Corporate Update, Outlook for 2019, and Year-End 2018 Financial Results
February 25th, 2019
VBI Vaccines Announces Phase 2 Clinical Study Design of its Prophylactic CMV Vaccine Candidate
December 20th, 2018
VBI Vaccines’ Late-Breaker Cytomegalovirus Abstract Chosen for Oral Presentation at IDWeek 2018
October 2nd, 2018
VBI Vaccines Announces Formation of New Scientific and Clinical Advisory Boards
September 26th, 2018
VBI Vaccines Announces Positive Final Phase 1 Study Results of Preventative CMV Vaccine
May 10th, 2018
VBI Vaccines to Present at The World Vaccine Congress Europe 2017 in Barcelona
October 11th, 2017
Developing Vaccine to Prevent Birth Defects from Cytomegalovirus
September 12th, 2017
VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine
July 27th, 2017
The State of U.S. CMV Legislation in 2017
June 27th, 2017
Researchers Explore the Possible Link between CMV Infection, Obesity, and Metabolic Syndrome
May 31st, 2017
VBI Vaccines Provides Update on its Congenital CMV Phase I Clinical Study
May 2nd, 2017
Researchers Assess Outcomes Following Passage of Utah CMV Legislation
April 7th, 2017
Researchers Explore Possible Link Between CMV and Acute Lymphocytic Leukemia (“ALL”)
January 23rd, 2017
VBI Vaccines Completes Enrollment of Participants in the Phase I Clinical Trial of its Preventative Cytomegalovirus Vaccine Candidate
September 20th, 2016
VBI Vaccines to Present at the Vaccine Congress
September 1st, 2016
VBI Vaccines to Continue Enrolling Participants in the Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate Following Successful Data Safety Monitoring Board Review
August 22nd, 2016
Researchers Explore Possible Link Between CMV and Alzheimer’s Disease
August 9th, 2016
Researchers Explore the Mechanisms by Which CMV Infection May Impact Fetal Brain Development
July 13th, 2016
VBI Vaccines Begins Enrolling Patients in a Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate
June 23rd, 2016
Page 1 of 4
1
2
3
4
›
Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI
Sign Up Now